Inositol 1,4,5-trisphosphate releases Ca2+ from a Ca2+-transporting membrane vesicle fraction derived from human platelets.
about
The role of phosphoinositide-regulated actin reorganization in chemotaxis and cell migrationInhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMPThe action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombinLight-stimulated inositolphospholipid turnover in Samanea saman leaf pulviniInositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thSubcellular distribution of Ca2+ pumping sites in human neutrophils.Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.Phorbol myristate acetate inhibits thrombin-stimulated Ca2+ mobilization and phosphatidylinositol 4,5-bisphosphate hydrolysis in human plateletsGTP- and inositol 1,4,5-trisphosphate-induced release of 45Ca2+ from a membrane store co-localized with pancreatic-islet-cell plasma membrane.Release of Ca2+ by inositol 1,4,5-trisphosphate in platelet membrane vesicles is not dependent on cyclic AMP-dependent protein kinaseInositol 1,4,5-trisphosphate-induced release of sequestered Ca2+ from highly purified human platelet intracellular membranes.MgATP-dependent accumulation of calcium ions and inorganic phosphate in a liver reticular pool.Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human plateletsCa2+ release from platelet intracellular stores by thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone: relationship to Ca2+ pools and relevance in platelet activation.myo-Inositol 1,4,5-trisphosphate mobilizes Ca2+ from isolated adipocyte endoplasmic reticulum but not from plasma membranes.Ca2+ release by inositol 1,4,5-trisphosphate is blocked by the K(+)-channel blockers apamin and tetrapentylammonium ion, and a monoclonal antibody to a 63 kDa membrane protein: reversal of blockade by K+ ionophores nigericin and valinomycin and puriStimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist.Extracellular Na+, but not Na+/H+ exchange, is necessary for receptor-mediated arachidonate release in platelets.Stimulated cholesterol-enriched platelets display increased cytosolic Ca2+ and phospholipase A activity independent of changes in inositol trisphosphates and agonist/receptor binding.Collagen-induced platelet activation mainly involves the protein kinase C pathwayConvulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway.The mechanism of action of GTP on Ca2+ efflux from rat liver microsomal vesicles.Further characterization of the plasma membrane- and intracellular membrane-associated platelet Ca2+ transport systems.The inositol 1,4,5-trisphosphate receptor binding sites of platelet membranes. pH-dependency, inhibition by polymeric sulphates, and the possible presence of arginine at the binding site.Ca2(+)-stimulatable and protein kinase C-inhibitable accumulation of inositol 1,3,4,6-tetrakisphosphate in human platelets.The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein kinase C on production of signal molecules.Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate aPossible mechanisms of the potentiation of blood-platelet activation by adrenaline.Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets.Receptor- and phorbol-ester-mediated redistribution of protein kinase C in human platelets. Evidence that aggregation promotes degradation of protein kinase C.Subcellular localization of the enzymes that dephosphorylate myo-inositol polyphosphates in human plateletsRole of type 1 and type 2A phosphatases in signal transduction of platelet-activating-factor-stimulated rabbit platelets.A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human plateletsSubcellular localization of inositol lipids in blood platelets as deduced from the use of labelled precursors.Isolation and characterization of a plasma membrane calcium pump from Dictyostelium discoideum.Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid.Binding of inositol trisphosphate by a liver microsomal fraction.Isolation of InsP4 and InsP6 binding proteins from human platelets: InsP4 promotes Ca2+ efflux from inside-out plasma membrane vesicles containing 104 kDa GAP1IP4BP protein.
P2860
Q27021287-B993FB50-E535-4E2A-A7BB-44CDA3038CD3Q28360355-5C69113D-4A2A-4EB9-B33A-BD8411387FC8Q28361275-5A2B2D93-C388-49B0-8C9F-6ED17369EA25Q34352498-6E732925-4C38-4C6C-BF08-9F15D5F28A53Q34568501-85E96C15-0B6E-4A2E-8539-442B9F9AAB99Q35575612-64CF7DA8-425A-4B1F-9D7E-28F4DD7BA684Q35883533-E8FC3FDD-D938-4179-9C61-55AB77082EFDQ37690602-B44671B2-B309-4B1F-87D6-2441AE75CD97Q41780505-ECDDAF83-EE57-4A92-BA28-C6D5775519BCQ41813695-99BF233A-3312-4D7F-9B05-4AD28C9A340CQ41853348-D75A1F9A-DB1A-4B87-B446-EB6441B55655Q41870232-311441DE-439C-4C31-A837-00D2534EF81CQ41878365-785F1DC9-A13C-4DCA-AC25-C1B4C3052ADCQ41882090-D5CDD798-A030-4E94-9E5B-DC8324FAC9BAQ41893496-2852D7AE-6457-4528-86AC-CF09F17C2573Q41945304-B346670D-8A10-4F6A-B3BC-E3565112659FQ41966630-50F717FA-9BDB-4EF0-A3D9-F4DA5C3C42A8Q41982549-AF4292D9-DCE5-49C1-AB6D-30CD41F64B0CQ42013974-5EF854A9-CE4C-43DC-8406-8715763500BBQ42018020-CDD3AC2D-658D-4A21-A9C7-C1A8E2656721Q42024590-398DA8BD-B1E6-4C71-8695-D1A9ABD51783Q42026442-6BA0DC68-752B-4283-BBB2-5BFE513F5D65Q42080482-0DF528E1-43E4-4543-A6D3-E98AD4A408FEQ42115621-D4C026F9-C227-4702-A555-A2341D93885DQ42124399-B667EBD3-F41E-48B1-B648-D2F72A7BB02BQ42136399-0B2A742C-CF2E-4212-A8FF-995857B6CD84Q42136461-546D4633-E5A5-42BD-83E3-100E9C1FCE89Q42136738-C5E42FD9-613C-45BD-97A8-930602028315Q42273582-832BE76C-E31F-46F5-88FC-86A951547A0EQ42748726-AE1B7C8E-70A7-49F5-965D-2C7E9796D827Q42804358-453BF692-232C-4DE1-8D04-F15232E4FA42Q42819071-F38C5CE7-1C83-4C67-8DCC-5FB6F62AB390Q42828154-DEA5626C-4E5C-4121-97FD-3A64B2D14229Q42855968-79E90C0F-B60D-4F97-980E-EBCD4FC24E51Q42856228-81C6AC48-F813-4EBC-AA81-66D6B1ACB033Q42857493-819948CA-76DF-4F36-9140-49B3C0329CF6Q42866943-34DF5900-2048-49C0-BB48-9DFDF75471CEQ42867586-8526DBE9-DDED-4A7A-8643-C599D8BE2658Q42981936-79572FAF-7C1F-4F85-8267-DA4E19D98172
P2860
Inositol 1,4,5-trisphosphate releases Ca2+ from a Ca2+-transporting membrane vesicle fraction derived from human platelets.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Inositol 1,4,5-trisphosphate r ...... derived from human platelets.
@en
type
label
Inositol 1,4,5-trisphosphate r ...... derived from human platelets.
@en
prefLabel
Inositol 1,4,5-trisphosphate r ...... derived from human platelets.
@en
P2093
P1476
Inositol 1,4,5-trisphosphate r ...... n derived from human platelets
@en
P2093
Feinstein MB
Halenda SP
O'Rourke FA
Zavoico GB
P304
P407
P577
1985-01-01T00:00:00Z